Previous Page  12 / 20 Next Page
Information
Show Menu
Previous Page 12 / 20 Next Page
Page Background

Page 35

Notes:

allied

academies

Res Rep Gynaecol Obstet 2017 | Volume 1 Issue 4

November 02-03, 2017 | Chicago, USA

Embryology and In vitro Fertilization

World Congress on

Clinical exome sequencing screening of subfertile individuals participating in in vitro fertilization

program: A pilot study

Anastasios Argyriou

1

, Danny Dafnis

1

, Ioannis Giakoumakis

1

and

Pantelis Constantoulakis

2

1

Mediterranean Fertility Institute, Greece

2

Science Labs Medical Institute, Athens, Greece

R

ecent advances in genome analysis using next generation

sequencing (NGS) allows simultaneously analyzing hundreds

and thousands of genes for mutations that either cause or

predispose to diseases and/or pathologic phenotypes. We

have chosen to apply an advanced clinical exome sequencing

panel (powered by Sophia Genetics DDM) on an Illumina

NextSeq-500 platform that analyses in detail at least 11 Mb

of human expressed DNA that contain more than 4500 genes

with disease- causing mutations, according to the Human Gene

Mutation Database (HGMD). We selected and targeted on 103

genes involved in human infertility, according to the Human

Phenotype Ontology (HPO) database, which uses updated

information from validated sources (Decipher, Orphanet,

OMIM). The population we studied in this preliminary effort

is 12 unrelated volunteers that were participating in IVF

programs and exhibited unexplained subfertility and 2 control

fertile subjects. Next generation sequencing and detailed

bioinformatics analysis of the infertility related genes revealed

pathogenic and/or likely pathogenic mutations in most of the

sub-fertile individuals, whereas no mutations were found in the

2 fertile controls in any of the genes studied. The number of

samples analyzed is very small to draw conclusive results, but

this pilot study suggests that genetic factors that predispose

various fertility related functions may play significant role in

cases of repeated IVF failures. Given the significant cost and

health burden of repeated efforts for fertilization this new

genomic era offers a novel approach in selecting the couples

that must think of alternative reproduction options.

Speaker Biography

Anastasios Argyriou has 31 years of professional and research experience in Biology of

Reproduction and Andrology. (Bachelor in Biology, University of Athens, Greece, DEA

in Endocrinology and Development, University of Caen, France, Diploma in Andrology,

University Paris XI, France, PhD in Physiology of Human Reproduction, University of

Paris VI, France). As a Senior Clinical Embryologist in IVF Laboratories, he has attended

multiple seminars in advanced IVF laboratory methods, teaching both undergraduate

and Post-graduate students and published scientific papers and articles. He delivered

lectures to academic and scientific audiences as a member of Greek and International

Scientific Associations and a regular member of the National Committee of Medically

Assisted Reproduction in Greece.

e:

a.argyriou@yahoo.gr